Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Cancer Research|October 3, 2007
FBXW7/hCDC4 is a general tumor suppressor in human cancerShahab Akhoondi, Dahui Sun, Natalie von der Lehr, et al.
Cell|September 1, 2023
Biomarkers of aging for the identification and evaluation of longevity interventionsMahdi Moqri, Chiara Herzog, Jesse R Poganik, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control SetsChiara Herzog, Fátima Marín, Allison Jones, et al.
Nature Medicine|February 15, 2024
Validation of biomarkers of agingMahdi Moqri, Chiara Herzog, Jesse R Poganik, et al.
Journal of the National Cancer Institute|January 30, 2016
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsPaul D P Pharoah, Honglin Song, Ed Dicks, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Genome Medicine|October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancerAndrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Cancer Research|October 3, 2007
FBXW7/hCDC4 is a general tumor suppressor in human cancerShahab Akhoondi, Dahui Sun, Natalie von der Lehr, et al.
Cell|September 1, 2023
Biomarkers of aging for the identification and evaluation of longevity interventionsMahdi Moqri, Chiara Herzog, Jesse R Poganik, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control SetsChiara Herzog, Fátima Marín, Allison Jones, et al.
Nature Medicine|February 15, 2024
Validation of biomarkers of agingMahdi Moqri, Chiara Herzog, Jesse R Poganik, et al.
Journal of the National Cancer Institute|January 30, 2016
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsPaul D P Pharoah, Honglin Song, Ed Dicks, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Genome Medicine|October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancerAndrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Pageof 18